149 related articles for article (PubMed ID: 8057132)
1. Survival following interstitial brachytherapy for recurrent malignant glioma.
Kitchen ND; Hughes SW; Taub NA; Sofat A; Beaney RP; Thomas DG
J Neurooncol; 1994; 18(1):33-9. PubMed ID: 8057132
[TBL] [Abstract][Full Text] [Related]
2. Interstitial brachytherapy versus cytoreductive surgery in recurrent malignant glioma.
Ryken TC; Hitchon PW; VanGilder JC; Wen BC; Jani S
Stereotact Funct Neurosurg; 1994; 63(1-4):241-5. PubMed ID: 7624640
[TBL] [Abstract][Full Text] [Related]
3. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas.
Leibel SA; Gutin PH; Wara WM; Silver PS; Larson DA; Edwards MS; Lamb SA; Ham B; Weaver KA; Barnett C
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1129-39. PubMed ID: 2557303
[TBL] [Abstract][Full Text] [Related]
4. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
Mamelak AN; Rosenfeld S; Bucholz R; Raubitschek A; Nabors LB; Fiveash JB; Shen S; Khazaeli MB; Colcher D; Liu A; Osman M; Guthrie B; Schade-Bijur S; Hablitz DM; Alvarez VL; Gonda MA
J Clin Oncol; 2006 Aug; 24(22):3644-50. PubMed ID: 16877732
[TBL] [Abstract][Full Text] [Related]
5. High activity iodine-125 interstitial implant for gliomas.
Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
[TBL] [Abstract][Full Text] [Related]
6. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564
[TBL] [Abstract][Full Text] [Related]
7. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.
Videtic GM; Gaspar LE; Zamorano L; Fontanesi J; Levin KJ; Kupsky WJ; Tekyi-Mensah S
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):687-92. PubMed ID: 10524423
[TBL] [Abstract][Full Text] [Related]
8. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
9. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
[TBL] [Abstract][Full Text] [Related]
10. [Extension of polynomial analysis of interstitial I-125 brachytherapy for 48 months].
Kolumbán Z; Major T; Julow J
Ideggyogy Sz; 2011 Jul; 64(7-8):235-8. PubMed ID: 21863690
[TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence in glioma patients after interstitial irradiation and chemotherapy: report of three cases.
Heros DO; Renkens K; Kasdon DL; Adelman LS
Neurosurgery; 1988 Mar; 22(3):474-8. PubMed ID: 3362313
[TBL] [Abstract][Full Text] [Related]
12. Intracranial interstitial radiation.
Willis D; Rittenmeyer H; Hitchon P
J Neurosci Nurs; 1986 Jun; 18(3):153-6. PubMed ID: 3014022
[TBL] [Abstract][Full Text] [Related]
13. Interstitial radiation in recurrent malignant gliomas.
Hitchon PW; Jani SK; VanGilder JC; Godersky JC; Doornbos S
Appl Neurophysiol; 1987; 50(1-6):292-4. PubMed ID: 3329866
[TBL] [Abstract][Full Text] [Related]
14. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
[TBL] [Abstract][Full Text] [Related]
15. Stereotaxic interstitial irradiation of malignant brain tumors.
Gutin PH; Leibel SA
Neurol Clin; 1985 Nov; 3(4):883-93. PubMed ID: 3001493
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
17. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
18. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
19. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas.
Loeffler JS; Alexander E; Hochberg FH; Wen PY; Morris JH; Schoene WC; Siddon RL; Morse RH; Black PM
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1455-62. PubMed ID: 2262370
[TBL] [Abstract][Full Text] [Related]
20. Stereotaxic irradiation of brain tumors.
Larson DA; Gutin PH; Leibel SA; Phillips TL; Sneed PK; Wara WM
Cancer; 1990 Feb; 65(3 Suppl):792-9. PubMed ID: 2154318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]